PMC9188911_01
a-e Course of blood counts for patients 1-5, relative to the first cycle of ICI ('day 0'). In patient 3, day '0' marks the first cycle of nivolumab; not the first cycle of priorly administered durvalumab
262_2022_3230_Fig1_HTML.jpg
PMC9188911_01_262_2022_3230_Fig1_HTML.jpg
Fig1